Medicalsystem Biotechnology Co., Ltd. (300439.SZ)
CNY 11.23
(-1.66%)
CNY 11.23
(-1.66%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 834.37 Million CNY | -19.24% |
| 2022 | 949.61 Million CNY | 4.2% |
| 2021 | 911.3 Million CNY | 7.43% |
| 2020 | 848.29 Million CNY | -21.28% |
| 2019 | 1.07 Billion CNY | -1.62% |
| 2018 | 1.09 Billion CNY | 10.86% |
| 2017 | 988.01 Million CNY | 72.88% |
| 2016 | 571.49 Million CNY | 42.47% |
| 2015 | 401.12 Million CNY | 19.58% |
| 2014 | 335.43 Million CNY | 33.61% |
| 2013 | 251.04 Million CNY | 29.65% |
| 2012 | 193.63 Million CNY | 67.84% |
| 2011 | 115.36 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 203.5 Million CNY | 24.26% |
| 2024 Q3 | 203.07 Million CNY | -14.56% |
| 2024 Q2 | 237.68 Million CNY | 16.79% |
| 2023 Q4 | 163.77 Million CNY | -27.44% |
| 2023 FY | 766.93 Million CNY | -19.24% |
| 2023 Q1 | 193.59 Million CNY | -14.07% |
| 2023 Q3 | 225.69 Million CNY | -6.26% |
| 2023 Q2 | 240.77 Million CNY | 24.37% |
| 2022 FY | 949.61 Million CNY | 4.2% |
| 2022 Q2 | 261.01 Million CNY | 17.97% |
| 2022 Q4 | 225.29 Million CNY | -6.92% |
| 2022 Q1 | 221.25 Million CNY | 6.91% |
| 2022 Q3 | 242.04 Million CNY | -7.27% |
| 2021 Q3 | 228.62 Million CNY | -5.79% |
| 2021 FY | 911.3 Million CNY | 7.43% |
| 2021 Q1 | 233.06 Million CNY | 32.03% |
| 2021 Q2 | 242.67 Million CNY | 4.12% |
| 2021 Q4 | 206.94 Million CNY | -9.48% |
| 2020 Q4 | 176.51 Million CNY | -36.28% |
| 2020 Q3 | 277.01 Million CNY | 12.79% |
| 2020 FY | 848.29 Million CNY | -21.28% |
| 2020 Q1 | 149.16 Million CNY | -37.92% |
| 2020 Q2 | 245.59 Million CNY | 64.64% |
| 2019 Q3 | 314.1 Million CNY | 28.93% |
| 2019 FY | 1.07 Billion CNY | -1.62% |
| 2019 Q4 | 240.27 Million CNY | -23.5% |
| 2019 Q2 | 243.63 Million CNY | -12.85% |
| 2019 Q1 | 279.55 Million CNY | -7.97% |
| 2018 Q1 | 221.01 Million CNY | -48.79% |
| 2018 Q4 | 303.76 Million CNY | 8.98% |
| 2018 Q2 | 291.85 Million CNY | 32.05% |
| 2018 Q3 | 278.72 Million CNY | -4.5% |
| 2018 FY | 1.09 Billion CNY | 10.86% |
| 2017 Q3 | 192.14 Million CNY | 1.02% |
| 2017 FY | 988.01 Million CNY | 72.88% |
| 2017 Q1 | 174.06 Million CNY | 3.3% |
| 2017 Q2 | 190.2 Million CNY | 9.27% |
| 2017 Q4 | 431.6 Million CNY | 124.63% |
| 2016 Q3 | 161.86 Million CNY | 19.56% |
| 2016 FY | 571.49 Million CNY | 42.47% |
| 2016 Q2 | 135.38 Million CNY | 28.05% |
| 2016 Q1 | 105.72 Million CNY | 18.16% |
| 2016 Q4 | 168.5 Million CNY | 4.1% |
| 2015 Q1 | 95.36 Million CNY | 6.37% |
| 2015 Q4 | 89.47 Million CNY | -25.04% |
| 2015 Q3 | 119.37 Million CNY | 23.19% |
| 2015 Q2 | 96.9 Million CNY | 1.62% |
| 2015 FY | 401.12 Million CNY | 19.58% |
| 2014 FY | 335.43 Million CNY | 33.61% |
| 2014 Q3 | 95.11 Million CNY | 21.08% |
| 2014 Q4 | 89.64 Million CNY | -5.75% |
| 2014 Q1 | 72.1 Million CNY | 0.0% |
| 2014 Q2 | 78.55 Million CNY | 8.95% |
| 2013 FY | 251.04 Million CNY | 29.65% |
| 2012 FY | 193.63 Million CNY | 67.84% |
| 2011 FY | 115.36 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 4.15 Billion CNY | 79.905% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.72 Billion CNY | 69.352% |
| Dirui Industrial Co.,Ltd. | 669.29 Million CNY | -24.664% |
| Beijing Strong Biotechnologies, Inc. | 1.3 Billion CNY | 35.835% |
| Maccura Biotechnology Co.Ltd | 1.51 Billion CNY | 44.8% |
| Guangzhou Wondfo Biotech Co.,Ltd | 1.72 Billion CNY | 51.617% |
| Guangdong Hybribio Biotech Co.,Ltd. | 662.35 Million CNY | -25.971% |
| BGI Genomics Co., Ltd. | 2.17 Billion CNY | 61.56% |
| Amoy Diagnostics Co., Ltd. | 871.54 Million CNY | 4.264% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 329.31 Million CNY | -153.367% |